Transfer Membrane Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 4.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Transfer Membrane Market Analysis
The Transfer Membrane Market is expected to register a CAGR of 4.5% during the forecast period.
The transfer membrane market is primarily driven by the increasing investment in R&D by pharmaceutical and biopharmaceutical companies and the development of new therapeutics for targeting chronic diseases. For instance, according to the European Commission Industrial R&D Investment prediction, data updated in December 2022, the United States planned to spend more than USD 679 billion on research and development in 2022. It was anticipated that China would spend roughly USD 551.1 billion on R&D in 2022. Hence, the high investment in R&D is believed to propel market growth as R&D opens doors for diagnostic research.
Furthermore, the growing prevalence of autoimmune and infectious diseases and the increasing focus on developing novel drug therapies based on DNA and RNA will boost market growth over the forecast period. According to the National Health Council data in March 2024, autoimmune diseases affect approximately 50 million Americans. More concerning is the trend, and the studies indicate an annual increase in autoimmune diseases of 3-12%, suggesting an almost epidemic rise. Therefore, the growing prevalence rate of autoimmune diseases is expected to increase R&D activities; in turn, the demand for transfer membranes is anticipated to upsurge. Eventually, these factors are expected to fuel the target market growth over the forecast period.
Moreover, in April 2022, Aviva Systems Biolocritical, a company that provides antibodies, immunoassay kits, and recombinant proteins for life sciences, launched its AvivaBlot product line of ECL reagents for western blot application. This new portfolio supports picogram to low femtogram detection of proteins via enhanced and stabilized chemiluminescent detection. Thus, the critical developments in the market, such as the increased launch and adoption of western blotting reagents, are also anticipated to foster the market’s growth due to the rise in the adoption of transfer membranes in western blot testing.
However, the availability of alternative methods for protein transfer with high efficiency and automation is anticipated to hamper the market growth.
Transfer Membrane Market Trends
Western Blotting Segment Expected to have Lucrative Growth Over the Forecast Period
Western blotting is a widely known and used cell and molecular biology test. It helps to detect the specific type of protein from the complex mixture of proteins extracted from the cell. This test has gained popularity in the market due to its accuracy, low cost, and ease of use. Western blot testing has a wide range of applications in medical diagnostics, including the diagnosis of diseases such as Bovine Spongiform Encephalopathy (BSE), Feline Immunodeficiency Virus (FIV), Hepatitis B Virus (HBV) infection, and Lyme Disease. Generally, this test is used to confirm the diseases mentioned above after the ELISA test has a positive result.
In addition, rising partnerships in the market for validating antibodies through western blot testing are anticipated to increase the adoption of this application and thereby surge the market demand. For instance, in February 2023, Bio-Techne and Cell Signaling Technology (CST) partnered to validate simple western antibodies, streamlining the study of crucial molecular signaling pathways for researchers. This collaboration promises an augmented selection of Simple Western validated antibodies, catering to various targets and disciplines.
Therefore, the target segment is projected to grow during the forecast period, owing to the abovementioned factors, such as the increased adoption of western blot techniques.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
The North American region is anticipated to have a significant market share owing to many R&D activities, considerable investments in developing new drugs, and support from public and private organizations for research. Moreover, the growing prevalence of chronic diseases coupled with rising targeted diseases in the region is anticipated to boost regional growth. For instance, according to the American Cancer Society's 2022 annual report, there were an estimated 1.9 million new cancer cases in the United States during 2022. Hence, this factor will positively influence the target market's growth in the forecast period.
Pharmaceutical companies' research and development budgets have also increased in the last few years, owing to the increasing focus on regulating markets, complex molecules, and therapy segments. For instance, according to the 2024 PhRMA Annual Membership Survey, the total amount spent on research and development by its member companies reached USD 101 billion in 2022. Therefore, the high R&D investment activities in the region are expected to increase the demand for transfer membranes, which, in turn, will aid the growth of the market studied in the area over the forecast period.
Thus, owing to the rising burden on chronic diseases and the high R&D investments by the biopharmaceutical companies in the region, the market is anticipated to boost significantly over the forecast period.
Transfer Membrane Industry Overview
The transfer membrane market is semi-consolidated, with a few key players operating. Factors owing to the competition include rising biopharmaceutical R&D investments, rising adoption of protein purification techniques, and key strategies adopted by the market players. Some companies operating in the market include Merck KGaA, PerkinElmer Inc., Pall Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Santa Cruz Biotechnology Inc., GE Healthcare, and ATTO Corporation.
Transfer Membrane Market Leaders
-
Merck KGaA
-
PerkinElmer, Inc.
-
Pall Corporation
-
Thermo Fisher Scientific
-
Bio-Rad Laboratories, Inc.
*Disclaimer: Major Players sorted in no particular order
Transfer Membrane Market News
- May 2024: Bio-Sourcing, in partnership with Ciloa and Intract Pharma, initiated a EUR 3.4 million (USD 3.7 million) project funded by the European Union. Dubbed the AB-BIOBETTER project, this three-year endeavor is focused on crafting an oral protein for antibody treatment.
- May 2024: Icosagen, a Contract Research and Development Manufacturing Organization (CRDMO) specializing in innovative antibody research and production, entered a strategic partnership with Lead Discovery Center GmbH (LDC). This collaboration aims to discover monoclonal antibody portfolios targeting therapeutically relevant proteins where the transfer membranes are commonly used.
Transfer Membrane Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Prevalence of Targeted Diseases and Introduction of New Treatment Technologies
- 4.2.2 Growing Public and Private Investments in Research
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Professionals
- 4.3.2 Availability of Alternative Technologies
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Type
- 5.1.1 Nitrocellulose Transfer Membrane
- 5.1.2 Polyvinylidene Fluoride (PVDF) Transfer Membrane
- 5.1.3 Nylon Transfer Membrane
-
5.2 By Transfer Method
- 5.2.1 Dry Electrotransfer
- 5.2.2 Semi-Dry Electrotransfer
- 5.2.3 Tank Elelctrotransfer
-
5.3 By Application
- 5.3.1 Western Blotting
- 5.3.2 Southern Blotting
- 5.3.3 Northern Blotting
- 5.3.4 Other Applications
-
5.4 By End User
- 5.4.1 Academic Research Institutions
- 5.4.2 Pharmacuitical and Biotechnological Companies
- 5.4.3 Other End Users
-
5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Middle East and Africa
- 5.5.4.1 GCC
- 5.5.4.2 South Africa
- 5.5.4.3 Rest of Middle East and Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Merck KGaA
- 6.1.2 PerkinElmer Inc.
- 6.1.3 Pall Corporation
- 6.1.4 Thermo Fisher Scientific
- 6.1.5 Bio-Rad Laboratories Inc.
- 6.1.6 Abcam plc
- 6.1.7 Santa Cruz Biotechnology Inc.
- 6.1.8 Axiva Sichem Biotech
- 6.1.9 ATTO Corporation
- 6.1.10 Macherey-Nagel
- 6.1.11 GE Healthcare
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Transfer Membrane Industry Segmentation
As per the scope, a transfer membrane is a microporous membrane used to detect and analyze proteins and nucleic acids. It is also used to transfer proteins from gel matrices and in various blotting techniques, such as northern, southern, western, and protein sequencing.
The transfer membrane market is segmented by type, transfer method, application, end-user, and geography. By type, the market is segmented into nitrocellulose transfer membrane, polyvinylidene fluoride (PVDF) transfer membrane, and nylon transfer membrane. By transfer method, the market is segmented into dry electrotransfer, semi-dry electrotransfer, and tank electrotransfer. By application, the transfer membrane market is segmented into western blotting, southern blotting, northern blotting, and other applications. By end user, the market is segmented into academic research institutions, pharmaceutical, biotechnological companies, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the abovementioned segments.
| By Type | Nitrocellulose Transfer Membrane | |
| Polyvinylidene Fluoride (PVDF) Transfer Membrane | ||
| Nylon Transfer Membrane | ||
| By Transfer Method | Dry Electrotransfer | |
| Semi-Dry Electrotransfer | ||
| Tank Elelctrotransfer | ||
| By Application | Western Blotting | |
| Southern Blotting | ||
| Northern Blotting | ||
| Other Applications | ||
| By End User | Academic Research Institutions | |
| Pharmacuitical and Biotechnological Companies | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Transfer Membrane Market Research FAQs
What is the current Transfer Membrane Market size?
The Transfer Membrane Market is projected to register a CAGR of 4.5% during the forecast period (2024-2029)
Who are the key players in Transfer Membrane Market?
Merck KGaA, PerkinElmer, Inc., Pall Corporation, Thermo Fisher Scientific and Bio-Rad Laboratories, Inc. are the major companies operating in the Transfer Membrane Market.
Which is the fastest growing region in Transfer Membrane Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Transfer Membrane Market?
In 2024, the North America accounts for the largest market share in Transfer Membrane Market.
What years does this Transfer Membrane Market cover?
The report covers the Transfer Membrane Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Transfer Membrane Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Transfer Membrane Industry Report
Statistics for the 2023 Transfer Membrane market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Transfer Membrane analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
